Bambusa Therapeutics News and Activities

Acquisition, funding and merger involving Bambusa Therapeutics.

• Bambusa Therapeutics has just announced a $90 Million fundraising (posted on February 21 2025).

View the org chart displaying its 11 main executives

Most searched biographies at Bambusa Therapeutics

• Shanshan Xu, Chief Executive Officer
• Derek Dirocco, Director
• Sean Marett, Director

Popular executive movements at Bambusa Therapeutics

• Todd James has joined the company as Chief Financial Officer  (posted on March 19 2026).

Create your alert
to follow the executive moves at Bambusa Therapeutics.

Bambusa Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Bambusa Therapeutics

Social media about Bambusa Therapeutics

• Bambusa Therapeutics on Wikipedia, Google News & Yahoo Finance
• Bambusa Therapeutics on LinkedIn, X (Twitter) & YouTube